UTI
UTI
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$20K
Insider Sales
0
$0
Total Volume
$20K
36 transactions
Net Activity
+$20K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$8597.38B total
Devincenzi Robert Thomas
Dir
$20K total
Quick Actions
UTI has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at UTI (UTI) engaged in a total of 36 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $20K.
The net insider activity for UTI shows a net buying bias of $20K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 6.31M shares valued at $4469.62B on Dec 1, 2025.
Universal Technical Institute (UTI) Q4 Earnings Miss Estimates
What Universal Technical Institute (UTI) Said on Its Q4 Earnings Call
Complicated UTI Care Strained by Unclear Goals, Access Gaps
Universal Technical Institute I (UTI) Stock Forecasts
Universal Technical Institute (UTI) Releases Q4 2026 Earnings: Revenue Growth but Misses Estimate
Universal Technical Institute Fiscal Q4 Earnings Fall, Revenue Rises; Shares Drop After Hours
Related News & Analyst Reports
Read original insights and educational research covering UTI and the Unknown sector.
The AI Circular Valuation Bubble: Inside the Venture-Cloud Loop
An in-depth investigation into how technology giants and AI startups engage in circular capital flows, investing venture capital in exchange for cloud services and hardware, creating a closed-loop economy that artificially inflates valuations.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
The Spinoff Separation: Tracking Post-Spinoff Executive Ownership Trends
An investigation of corporate spinoffs, showing how executive equity allocations and post-separation insider transactions signal parent and subsidiary performance trajectories.
The Lockup Expiration Wave: Venture Capital Post-IPO Exit Strategies
A data-driven analysis of how venture capital firms and pre-IPO insiders manage lockup expirations, detailing block trade execution, distribution methods, and stock price impact.
a16z Capital Distributions vs. Open-Market Insider Buying: A 2026 Study
A 2026 empirical study comparing Andreessen Horowitz's in-kind share distributions to LPs against open-market insider purchases, revealing which signal better predicts 12-month price performance.
Institutional Ownership vs. Insider Trading: Understanding the Data Flow
High institutional ownership reduces information asymmetry, but does it also reduce the predictive power of insider trades? This analysis tests whether stocks with more than 70% institutional ownership show weaker Form 4 signal performance.
FAQs About UTI Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for UTI.